NRC Health price to free cash flow NRC

Market value divided by free cash flow over the last twelve months, since 2013.

Today, Oct 23, 2026: 22.4×
10-year median: 31.0×
Against its 10-year history: 17th; percentile: 0 is its lowest day, 100 its highest
10-year range: 12.6× to 53.8×
Peer median: 22.7×

NRC Health's price to free cash flow is 22.4× as of Oct 23, 2026.

That is below its ten-year median of 31.0×, lower than on 83% of days in the last ten years.

Over that time it ranged from 12.6× in Apr 2025 to 53.8× in Sep 2023.

The median for 3 diagnostics and research stocks of a similar size is 22.7×.

Price to free cash flow over time

median 31×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	22.4×	20.0×	43.3×
2025	36.4×	12.6×	39.8×
2024	16.3×	16.0×	48.0×
2023	47.3×	32.4×	53.8×
2022	30.0×	21.2×	31.8×
2021	23.4×	23.1×	40.0×
2020	33.1×	27.2×	44.9×
2019	43.3×	28.1×	50.3×
2018	36.2×	28.7×	39.4×
2017	35.1×	19.0×	42.1×
2016	21.8×	15.2×	21.8×
2015	22.0×	13.7×	22.9×
2014	15.6×	14.3×	26.6×
2013	23.3×	5.3×	29.6×

Against its peers

Companies in Medical - Diagnostics & Research nearest NRC Health's size, closest first, today.

Company	Price to free cash flow
NRCNRC Health	22.4×
ICCCImmucell	22.1×
CDNACareDx	n/m
VCYTVeracyte	23.2×
Peer median	22.7×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on NRC Health

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.